Paid Clinical Trials Henderson
Discover 433 paid clinical trials in Henderson, Nevada. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Danvatirsen & PembrolizumabActivity and Safety of Danvatirsen and Pembrolizumab in HNSCC
Sponsor:
Flamingo Therapeutics NV
Location:
Code:
NCT05814666
Conditions
HNSCC
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Danvatirsen
Pembrolizumab
GSK4172239DA Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years
Sponsor:
GlaxoSmithKline
Location:
Code:
NCT05660265
Conditions
Hematologic Diseases
Anaemia, Sickle Cell
Eligibility Criteria
Sex: All
Age: 18 - 50
Healthy Volunteers: Not accepted
Interventions
GSK4172239D
Placebo
RimegepantA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Sponsor:
Pfizer
Location:
Code:
NCT06641466
Conditions
Menstrual Migraine
Eligibility Criteria
Sex: Female
Age: 18 - 45
Healthy Volunteers: Not accepted
Interventions
Rimegepant
Placebo Comparator
Standard of Care
LenalidomideMCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients
Sponsor:
St. Joseph's Hospital and Medical Center, Phoenix
Location:
Code:
NCT04032626
Conditions
Cognitive Impairment, Mild
Cognitive Dysfunction
Amyloid Plaque
Neurodegeneration
Inflammation, Brain
Eligibility Criteria
Sex: All
Age: 50 - 70+
Healthy Volunteers: Not accepted
Interventions
Lenalidomide 10 mg
Placebo
Combination ChemotherapyCombination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Sponsor:
University of Leicester
Location:
Code:
NCT00020566
Conditions
Sarcoma
Eligibility Criteria
Sex: All
Age: 0 - 49
Healthy Volunteers: Not accepted
Interventions
dactinomycin
busulfan
doxorubicin hydrochloride
etoposide
ifosfamide
PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Sponsor:
89bio, Inc.
Location:
Code:
NCT06419374
Conditions
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Pegozafermin
Placebo
Cortical ModulationModulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain
Sponsor:
University of Nevada, Las Vegas
Location:
Code:
NCT06565520
Conditions
Patellofemoral Pain Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 45
Healthy Volunteers: Not accepted
Interventions
transcranial direct current stimulator
CIN-103Study of the Research Medicine CIN-103 in Adults with Irritable Bowel Syndrome with Predominant Diarrhea (IBS-D).
Sponsor:
CinPhloro Pharma, LLC
Location:
Code:
NCT06153420
Conditions
Irritable Bowel Syndrome with Diarrhea
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CIN-103
Placebo
ImmunotherapyTesting the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT05647265
Conditions
Pleural Biphasic Mesothelioma
Pleural Sarcomatoid Mesothelioma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Ipilimumab
Surgical Procedure
Computed Tomography
Magnetic Resonance Imaging